Eric R Kalkman

5PUBLICATIONS
27CO-AUTHORS
Molecular targetsHaematological tumoursCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.

Ahmed Khalaf, Lucie de Beauchamp, Eric Kalkman

|Aug 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells.

Kevin M Rattigan, Zuzana Brabcova, Daniele Sarnello

|Jul 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.

Kevin M Rattigan, Martha M Zarou, Zuzana Brabcova

|Sep 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy.

Angela Ianniciello, Martha M Zarou, Kevin M Rattigan

|May 10, 2019
An in vitro model for studying CNS white matter: functional properties and experimental approaches.

Silvia Bijland, Gemma Thomson, Matthew Euston

Pageof 1